Home

EDGAR ENGLEMAN

CIK 1227162 · last filed 2023-12-01

EDGAR ENGLEMAN is a corporate insider who has filed 28 SEC Form 4 insider transactions across 6 companies since 2014. The most recent filing shows the insider sold $129.0K of BOLT on Dec 1, 2023. Across all open-market trades the lifetime net is +$7.2M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.15M

Companies

6

Total Filings

28

Lifetime Open-Market Net

$7.17M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BOLT Director 13,323 $4.02 $53.6K $3.82M 7 2023-12-01
SOLENO THERAPEUTICS INC (SLNOW) Delisted Director 4,027,292 — — $2.00M 4 2018-02-07
SOLENO THERAPEUTICS INC (CAPNW) Delisted Director 14,652,610 — — $1.35M 2 2017-05-09
Eiger BioPharmaceuticals, Inc. (EIGR) Delisted Director — $1.73 — $0 3 2017-04-13
SOLENO THERAPEUTICS INC (CAPN.W) Delisted Director 9,823,011 — — $0 10 2016-06-10
RGNX Director 114,108 $9.60 $1.10M $0 2 2015-09-22

Recent Filings

28 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-12-01 BOLT Sell (S) −148,884 -$129.0K EDGAR
2023-11-22 BOLT Sell (S) −1,943 -$1.8K EDGAR
2023-11-20 BOLT Sell (S) −49,173 -$45.7K EDGAR
2023-06-14 BOLT Grant (A) — $0 EDGAR
2022-06-10 BOLT Grant (A) — $0 EDGAR
2022-03-28 BOLT Grant (A) — $0 EDGAR
2021-02-09 BOLT Mixed +2,244,435 $4.00M EDGAR
2018-02-07 SOLENO THERAPEUTICS INC (SLNOW) Delisted Grant (A) +5,068 $8.7K EDGAR
2017-12-19 SOLENO THERAPEUTICS INC (SLNOW) Delisted Buy (P) +1,085,480 $2.00M EDGAR
2017-10-04 SOLENO THERAPEUTICS INC (SLNOW) Delisted Grant (A) +16,827 $8.8K EDGAR
Showing 1–10 of 28
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.